Account Type******* ***Account Owner******* *******Account Opps/Deals**** ****Closed Won • Jan 25****K $Closed
****** ****Worked in execs roles at *** together from 2021-2024****** *****Worked in the same department at *** together from 2021-2024
Eli Lilly And CompanyGlobal Regulatory Strategy Leader in Oncology, Early and Late PhaseFeb 08 - PresentNovartisPostdoctoral Fellow - Immunotoxicology, Basel, SwitzerlandMar 06- Jan 08University Of TorontoPhD - Immunotoxicology, Toronto, CanadaSep 00- Feb 06
Scott RiniVP Of EngineeringView Profile, Scott RiniOlivier GossiauxCTO Chief Technology OfficerView Profile, Olivier GossiauxNathan ReynoldsVice President Of EngineeringView Profile, Nathan Reynolds